The cerebrovascular dilatation effects of olprinone, a phosphodiesterase III inhibitor, in comparison with acetazolamide--a pilot study.

Source:http://linkedlifedata.com/resource/pubmed/id/15297001

Download in:

View as

General Info

PMID
15297001